Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study
Authors:
- Candice SabbenCSCandice Sabben
- Frédérique CharbonneauFCFrédérique Charbonneau
- François DelvoyeFDFrançois Delvoye
- Davide StramboDSDavide Strambo
- Mirjam R. HeldnerMirjam R. Heldner
- Hilde HenonHHHilde Henon
- Wagih Ben HassenWHWagih Ben Hassen
- Thomas Agasse-LafontTAThomas Agasse-Lafont
- Loïc LegrisLLLoïc Legris
- Igor SibonISIgor Sibon
- 1 April 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (4) , 928-937
Abstract
Background: Whether endovascular therapy (EVT) added on best medical management (BMM), as compared to BMM alone, is beneficial in acute ischemic stroke with isolated posterior cerebral artery occlusion is unknown. Methods: We conducted a multicenter international observational study of consecutive stroke patients admitted within 6 hours from symptoms onset in 26 stroke centers with isolated occlusion of the first (P1) or second (P2) segment of the posterior cerebral artery and treated either with BMM+EVT or BMM alone. Propensity score with inverse probability of treatment weighting was used to account for baseline between-groups differences. The primary outcome was 3-month good functional outcome (modified Rankin Scale [mRS] score 0–2 or return to baseline modified Rankin Scale). Secondary outcomes were 3-month excellent recovery (modified Rankin Scale score 0–1), symptomatic intracranial hemorrhage, and early neurological deterioration. Results: Overall, 752 patients were included (167 and 585 patients in the BMM+EVT and BMM alone groups, respectively). Median age was 74 (interquartile range, 63–82) years, 329 (44%) patients were female, median National Institutes of Health Stroke Scale was 6 (interquartile range 4–10), and occlusion site was P1 in 188 (25%) and P2 in 564 (75%) patients. Baseline clinical and radiological data were similar between the 2 groups following propensity score weighting. EVT was associated with a trend towards lower odds of good functional outcome (odds ratio, 0.81 [95% CI, 0.66–1.01]; P =0.06) and was not associated with excellent functional outcome (odds ratio, 1.17 [95% CI, 0.95–1.43]; P =0.15). EVT was associated with a higher risk of symptomatic intracranial hemorrhage (odds ratio, 2.51 [95% CI, 1.35–4.67]; P =0.004) and early neurological deterioration (odds ratio, 2.51 [95% CI, 1.64–3.84]; P <0.0001). Conclusions: In this observational study of patients with proximal posterior cerebral artery occlusion, EVT was not associated with good or excellent functional outcome as compared to BMM alone. However, EVT was associated with higher rates of symptomatic intracranial hemorrhage and early neurological deterioration. EVT should not be routinely recommended in this population, but randomization into a clinical trial is highly warranted.Keywords
This publication has 21 references indexed in Scilit:
- Importance of the Intention-to-Treat PrincipleJAMA Neurology, 2020
- Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery OcclusionStroke, 2020
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2018
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studiesInternational Journal of Surgery, 2014
- Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for StrokeStroke, 2014
- Lower NIH Stroke Scale Scores Are Required to Accurately Predict a Good Prognosis in Posterior Circulation StrokeCerebrovascular Diseases, 2014
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokesNeurology, 2008
- Posterior Cerebral Artery Territory Infarcts: Clinical Features, Infarct Topography, Causes and Outcome1Cerebrovascular Diseases, 2000
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998